AR010550A1 - CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM. - Google Patents

CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM.

Info

Publication number
AR010550A1
AR010550A1 ARP970105152A ARP970105152A AR010550A1 AR 010550 A1 AR010550 A1 AR 010550A1 AR P970105152 A ARP970105152 A AR P970105152A AR P970105152 A ARP970105152 A AR P970105152A AR 010550 A1 AR010550 A1 AR 010550A1
Authority
AR
Argentina
Prior art keywords
lower alkyl
alkyl
phenyl
hydroxy
heterocyclyl
Prior art date
Application number
ARP970105152A
Other languages
Spanish (es)
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of AR010550A1 publication Critical patent/AR010550A1/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Derivados de cefalosporina de formula general (I) en la que R1 es halogeno, alquilo inferior, fenilo, bencilo, estirilo, naftilo o heterociclilo; estandoel alquilo inferior, fenilo, bencilo, estirilo naftilo y heterociclilo opcionalmentesus tituido por al menos uno de halogeno, hidroxi, alquiloinferior, opocionalmente sustituido, alcoxi inferior opcionalmente sustituido, fenilo opcionalmente sustituido, amino, alquil-inferior-amino, di-alquil-inferior-amino, carboxi, alquil-inferior-ca rboxi, o carbamoílo; o alquil- inferior carbamoilo; R4 y R5 son independientemente hidrogeno, alquilo inferioro fenilo; X es S, O, NH o CH2; n es 0, 1 o 2; m es 0 o 1; s es 0 o 1; R2 es hidrogeno, hidroxi, -CH2-CONHR6 alquilo-inferior- Qr, cicloalquilo-Qr, alcoxiinferior, alquenilo inferior, cicloalquenilo-Qr, alquinilo inferior, aralquilo- Qr, arilo-Qr, ariloxi, aralcoxi, un anillo heterocíclico o un heterociclilo-Qr,el alquilo inferior, cicloalquilo, alcoxi inferior,alquenilo inferi or, aralquilo, arilo, ariloxi, aralcoxi y el anillo hterocíclico pueden estarsustituidos con al menos un grupo seleccionado de carboxi, amnio, nitro, ciano, -SO2NHR6 alquilo inferior opcionalmente sustituido con fluoro,alcoxi inferior,hidrox i, halogeno, -CONR6R7, -CHCONR6R7, -N(R7)COOR8, R7CO-, R7OCO-, R7COO-, -C(R7R9)CO2R8, -C(R7R9)CONR7R10, donde R6 es hidrogeno, alquilo inferior ocicloalquilo o arilo; R7 y R9 son independientemente hidrogeno o alquiloinferior; R8 es hidrog eno, alquilo inferior, alquenilo infeior o un grupoprotector de ácido carboxílico; y R10 es hidrogeno, omega-hidroxi-alquilo, fenilo, naftilo o heterociclilo, estando el fenilo, naftilo heterociclilo nosustituido osustituidos con al menos uno de los grupos de hidrox opcionalmente protegido, halogeno, alquilo inferior o omega-hidroxialquiloCephalosporin derivatives of general formula (I) in which R1 is halogen, lower alkyl, phenyl, benzyl, styryl, naphthyl or heterocyclyl; lower alkyl, phenyl, benzyl, naphthyl styryl and heterocyclyl being optionally substituted by at least one of halogen, hydroxy, lower alkyl, optionally substituted, optionally substituted lower alkoxy, optionally substituted phenyl, amino, lower alkyl-amino, di-lower alkyl. -amino, carboxy, lower-alkyl-ca rboxi, or carbamoyl; or lower alkyl carbamoyl; R4 and R5 are independently hydrogen, lower alkyl, or phenyl; X is S, O, NH or CH2; n is 0, 1 or 2; m is 0 or 1; s is 0 or 1; R2 is hydrogen, hydroxy, -CH2-CONHR6 lower-alkyl-Qr, cycloalkyl-Qr, lower alkoxy, lower alkenyl, cycloalkenyl-Qr, lower alkynyl, aralkyl-Qr, aryl-Qr, aryloxy, aralkoxy, a heterocyclic ring or a heterocyclyl -Qr, lower alkyl, cycloalkyl, lower alkoxy, lower alkenyl, aralkyl, aryl, aryloxy, aralkoxy and the heterocyclic ring may be substituted with at least one group selected from carboxy, amnium, nitro, cyano, -SO2NHR6 lower alkyl optionally substituted with fluoro, lower alkoxy, hydroxy i, halogen, -CONR6R7, -CHCONR6R7, -N (R7) COOR8, R7CO-, R7OCO-, R7COO-, -C (R7R9) CO2R8, -C (R7R9) CONR7R10, where R6 is hydrogen, lower alkyl or cycloalkyl or aryl; R7 and R9 are independently hydrogen or lower alkyl; R8 is hydroxy, lower alkyl, lower alkenyl, or a carboxylic acid protecting group; and R10 is hydrogen, omega-hydroxy-alkyl, phenyl, naphthyl, or heterocyclyl, with phenyl, naphthyl heterocyclyl being unsubstituted or substituted with at least one of the optionally protected hydroxy, halogen, lower alkyl, or omega-hydroxyalkyl groups.

ARP970105152A 1996-11-06 1997-11-05 CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM. AR010550A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96117710 1996-11-06

Publications (1)

Publication Number Publication Date
AR010550A1 true AR010550A1 (en) 2000-06-28

Family

ID=8223370

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105152A AR010550A1 (en) 1996-11-06 1997-11-05 CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM.

Country Status (11)

Country Link
AR (1) AR010550A1 (en)
BR (1) BR9705434A (en)
CO (1) CO4910157A1 (en)
HR (1) HRP970588A2 (en)
ID (1) ID18086A (en)
PE (1) PE10799A1 (en)
PL (1) PL323001A1 (en)
TR (1) TR199701299A2 (en)
UY (1) UY24769A1 (en)
YU (1) YU43797A (en)
ZA (1) ZA979955B (en)

Also Published As

Publication number Publication date
PE10799A1 (en) 1999-02-10
BR9705434A (en) 1999-05-11
ZA979955B (en) 1998-05-06
TR199701299A2 (en) 1998-05-21
UY24769A1 (en) 2000-12-29
MX9708525A (en) 1998-05-31
ID18086A (en) 1998-02-26
YU43797A (en) 1999-11-22
PL323001A1 (en) 1998-05-11
HRP970588A2 (en) 1998-10-31
CO4910157A1 (en) 2000-04-24

Similar Documents

Publication Publication Date Title
AR023289A1 (en) COMPOUNDS WITH INHIBITING ACTIVITY OF NEUTRAL ENDOPEPTIDASE (NEP), PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND PROCEDURE FOR PREPARATION.
HUP0003929A2 (en) Piperazine derivatives and their use for producing pharmaceutical compositions as anti-inflammatory agents and pharmaceutical compositions containing them
ES2070186T3 (en) NEW DERIVATIVES OF 2,4-DIAMINO-PIRIMIDINA-3-OXIDO AND ITS USE IN THE PREVENTION OF HAIR LOSS.
DK0628311T3 (en) Xanthine derivatives as antidepressants
MX9305379A (en) NEW AMINO ACID DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION CONTAINING THEM.
CL2003002756A1 (en) COMPOUNDS DERIVED FROM (1-CARBAMOIL-1,1-DEFENILMETIL) -1- [SUBSTITUTED) RENT] PURROLIDINES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF THE IRRITABLE INTESTINE SYNDROME OR INCONTINENCE.
ES2162676T3 (en) PHENYLENE DERIVATIVES REPLACED IN META AND ITS USE AS ANTAGONISTS OR INHIBITORS OF INTEGRINA ALFAV, BETA3.
HUP9700328A2 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
ES2195382T3 (en) INDOLCARBOXYL COMPOUNDS AND THEIR USE AS PHARMACEUTICAL COMPOUNDS.
CO4990934A1 (en) DERIVATIVES OF TIAZOLE
UY25211A1 (en) ISOQUINOLINYLGUANIDINE UROKINASE INHIBITORS
PT83535B (en) METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMINO ACID DERIVATIVES
ES2098023T3 (en) GUANIDINIC STRUCTURE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE59812576D1 (en) USE OF 1-SUBSTITUTED ISATINES FOR STAINING KERATIN-CONTAINING FIBERS
ATE421524T1 (en) 5-RING HETEROCYCLES, THEIR PRODUCTION, THEIR USE AS INHIBITORS OF LEUKOCYTE ADHESION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
MX9400253A (en) DERIVATIVES OF PIPERAZINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DK0553016T3 (en) New Naphthalenamides and Sulfonamides, Methods for their Preparation, and Pharmaceutical Agents Containing Them
ES2058572T3 (en) NEW DERIVATIVES OF UREYLENE-2,4,6-TRIAMINE-PIRIMIDINE-3-OXIDE, ITS PREPARATION AND ITS USE IN COSMETICS AND DERMOPHARMACY.
AR010550A1 (en) CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
PT873993E (en) NEW HETEROCYCLIC COMPOUNDS PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ATE189894T1 (en) NAPHTHAMIDE DERIVATIVES OF 3-BETA-AMINO AZABICYCLOOCTAN OR NONANE AS ANTIPSYCHOTIC DRUGS
DK0466662T3 (en) 6,7-Disubstituted-2-aminotetralins active as immunomodulators, as well as pharmaceutical preparations containing such compounds
AR013004A1 (en) DERIVATIVES OF AMINOSPIROPIPERIDINE QUINAZOLINE, PHARMACEUTICAL COMPOSITION, USE OF SUCH DERIVATIVES IN THE PREPARATION OF MEDICINES, PROCESS FOR THE PREPARATION OF SUCH DERIVATIVES AND INTERMEDIATE COMPOUNDS FOR ITS EXCLUSIVE USE IN SUCH PROCESS.
AR005454A1 (en) DERIVATIVES OF ISOOXACEFEM, ITS USE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH DERIVATIVES.
SE7508829L (en) DIPEPTID DERIVATIVES.

Legal Events

Date Code Title Description
FG Grant, registration